Literature DB >> 27157106

Zika Virus: What Do Emergency Physicians Need to Know?

Drew Long1, Brit Long2, Alex Koyfman3.   

Abstract

BACKGROUND: Zika virus currently dominates headlines, creating public fear due to its complications. With the ease of worldwide travel, this disease has spread rapidly to the U.S.
OBJECTIVES: To provide physicians with an updated clinical review of the epidemiology, pathogenesis, diagnosis, management, and mimics of zika virus. DISCUSSION: This flavivirus is spread by the bite of the Aedes mosquito during daylight. The ease of worldwide travel has allowed the virus to spread to Mexico and the U.S. Main transmission route is via blood contact or sexual activity involving mucous membranes. Incubation ranges from 2 to 12 days, but only 20% of patients experience symptoms. Fever is low grade with conjunctivitis, arthralgias, myalgias, and a maculopapular rash. Chikungunya and Dengue Fever differ in that patients experience higher fever and no conjunctivitits. The dreaded complication of Zika virus is microcephaly in infants born to infected mothers. Guillain-Barre Syndrome is also linked to the virus. Historical factors including travel history are paramount, and diagnosis includes PCR or serology. No current treatment regimen exists beyond symptom control. The emergency physician must seek to rule out other similar diseases such as malaria, chikungunya, and dengue fever.
CONCLUSION: Zika virus has created public fear due to complications, and this flavivirus spread by the Aedes mosquito presents similarly to Chikungunya and Dengue Fever. The dreaded complication of Zika virus is microcephaly in infants born to infected mothers. This review provides key information concerning the disease and management.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aedes; Zika virus; blood; flavivirus; microcephaly; mosquito

Mesh:

Year:  2016        PMID: 27157106     DOI: 10.1016/j.jemermed.2016.03.033

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  4 in total

1.  Sporadic cases of adult measles: a research article.

Authors:  Ranjan Premaratna; Nathasha Luke; Harsha Perera; Mahesh Gunathilake; Pubudu Amarasena; T G A Nilmini Chandrasena
Journal:  BMC Res Notes       Date:  2017-01-10

2.  A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses.

Authors:  Kara M Pryke; Jinu Abraham; Tina M Sali; Bryan J Gall; Iris Archer; Andrew Liu; Shelly Bambina; Jason Baird; Michael Gough; Marita Chakhtoura; Elias K Haddad; Ilsa T Kirby; Aaron Nilsen; Daniel N Streblow; Alec J Hirsch; Jessica L Smith; Victor R DeFilippis
Journal:  mBio       Date:  2017-05-02       Impact factor: 7.867

3.  Trimerization of the N-Terminal Tail of Zika Virus NS4A Protein: A Potential In Vitro Antiviral Screening Assay.

Authors:  Janet To; Jaume Torres
Journal:  Membranes (Basel)       Date:  2021-04-30

Review 4.  The Zika virus: Lurking behind the COVID-19 pandemic?

Authors:  Joseph Pergolizzi; Jo Ann LeQuang; Sumiyo Umeda-Raffa; Charles Fleischer; Joseph Pergolizzi; Claudio Pergolizzi; Robert B Raffa
Journal:  J Clin Pharm Ther       Date:  2020-11-20       Impact factor: 2.145

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.